Advisory Committee on the Medical Uses of Isotopes: Meeting Notice, 32207-32208 [2017-14543]

Download as PDF Federal Register / Vol. 82, No. 132 / Wednesday, July 12, 2017 / Notices Comptroller 5. Report on the FY 2018 appropriations process • Carol Bergman, Vice President for Government Relations & Public Affairs 6. Consider and act on Temporary Operating Authority for FY 2018 Resolution 2017–XXX • David Richardson, Treasurer/ Comptroller 7. Public Comment 8. Consider and act on other business 9. Consider and act on adjournment of meeting July 21, 2017 Operations & Regulations Committee Open Session 1. Approval of agenda 2. Approval of minutes of the Committee’s Open Session meeting on April 23, 2017 3. Approval of minutes of the Committee’s Open Session telephonic meeting of May 23, 2017 4. Consider and act on a Final Rule for 45 CFR parts 1600, 1630 and 1631— Costs and Property • Ron Flagg, Vice President for Legal Affairs, General Counsel and Corporate Secretary • Mark Freedman, Senior Associate General Counsel 5. Consider and act on a Final Rule for 45 CFR part 1629—Bonding • Ron Flagg, Vice President for Legal Affairs, General Counsel and Corporate Secretary • Tyler Ellis, Law Fellow 6. Consider and act on the 2017—2018 Rulemaking Timeline • Ron Flagg, Vice President for Legal Affairs, General Counsel and Corporate Secretary 7. Report on revised 2018 Grant Terms and Conditions • Ron Flagg, Vice President for Legal Affairs, General Counsel and Corporate Secretary • Mark Freedman, Senior Associate General Counsel 8. Public comment 9. Consider and act on other business 10. Consider and act on motion to adjourn meeting July 22, 2017 asabaliauskas on DSKBBXCHB2PROD with NOTICES Board of Directors Open Session 1. Pledge of Allegiance 2. Approval of agenda 3. Approval of minutes of the Board’s Open Session meeting of April 24, and April 25, 2017 4. Approval of minutes of the Board’s Open Session telephonic meeting of May 23, 2017 VerDate Sep<11>2014 17:54 Jul 11, 2017 Jkt 241001 5. Chairman’s Report 6. Members’ Report 7. President’s Report 8. Inspector General’s Report 9. Consider and act on the report of the Audit Committee 10. Consider and act on the report of the Governance and Performance Review Committee 11. Consider and act on the report of the Delivery of Legal Services Committee 12. Consider and act on the report of the Institutional Advancement Committee 13. Consider and act on the report of the Finance Committee 14. Consider and act on the report of the Operations and Regulations Committee 15. Consider and act on Resolution 2017–XXX, in Recognition and Profound Appreciation of Charles N.W. Keckler’s Distinguished Service 16. Public Comment 17. Consider and act on other business 18. Consider and act on motion to adjourn the open session meeting and proceed to a closed session Closed Session 1. Approval of minutes of the Board’s Closed Session meeting of April 25, 2017 2. Management briefing 3. Inspector General briefing 4. Consider and act on list of prospective Leaders Council members 5. Consider and act on General Counsel’s briefing on potential and pending litigation involving LSC 6. Consider and act on motion to adjourn meeting CONTACT PERSON FOR INFORMATION: Katherine Ward, Executive Assistant to the Vice President & General Counsel, at (202) 295–1500. Questions may be sent by electronic mail to FR_NOTICE_ QUESTIONS@lsc.gov. NON-CONFIDENTIAL MEETING MATERIALS: Non-confidential meeting materials will be made available in electronic format at least 24 hours in advance of the meeting on the LSC Web site, at http:// www.lsc.gov/board-directors/meetings/ board-meeting-notices/non-confidentialmaterials-be-considered-open-session. ACCESSIBILITY: LSC complies with the American’s with Disabilities Act and Section 504 of the 1973 Rehabilitation Act. Upon request, meeting notices and materials will be made available in alternative formats to accommodate individuals with disabilities. Individuals who need other accommodations due to disability in PO 00000 Frm 00048 Fmt 4703 Sfmt 4703 32207 order to attend the meeting in person or telephonically should contact Katherine Ward, at (202) 295–1500 or FR_ NOTICE_QUESTIONS@lsc.gov, at least 2 business days in advance of the meeting. If a request is made without advance notice, LSC will make every effort to accommodate the request but cannot guarantee that all requests can be fulfilled. Dated: July 10, 2017. Katherine Ward, Executive Assistant to the Vice President for Legal Affairs, General Counsel & Corporate Secretary. [FR Doc. 2017–14767 Filed 7–10–17; 4:15 pm] BILLING CODE 7050–01–P LEGAL SERVICES CORPORATION Sunshine Act Meeting: Finance Committee; Postponed Legal Services Corporation. Postponement notice. AGENCY: ACTION: On June 26, 2017, the Legal Services Corporation (LSC) published a notice in the Federal Register (82 FR 28910) titled ‘‘Finance Committee Telephonic Meeting on July 10, 2017 at 3:00 p.m., EDT.’’ The meeting has been postponed, and the agenda will be covered at a later date. This document announces the postponement of the meeting. SUMMARY: This postponement is effective July 10, 2017. FOR FURTHER INFORMATION CONTACT: Katherine Ward, Executive Assistant to the Vice President for Legal Affairs and General Counsel, Legal Services Corporation, 3333 K Street NW., Washington, DC 20007; (202) 295–1500; kward@lsc.gov. DATES: Dated: July 10, 2017. Katherine Ward, Executive Assistant to the Vice President for Legal Affairs and General Counsel. [FR Doc. 2017–14685 Filed 7–10–17; 11:15 am] BILLING CODE 7050–01–P NUCLEAR REGULATORY COMMISSION Advisory Committee on the Medical Uses of Isotopes: Meeting Notice U.S. Nuclear Regulatory Commission. ACTION: Notice of meeting. AGENCY: The U.S. Nuclear Regulatory Commission will convene a meeting of the Advisory Committee on the Medical Uses of Isotopes (ACMUI) on September SUMMARY: E:\FR\FM\12JYN1.SGM 12JYN1 32208 Federal Register / Vol. 82, No. 132 / Wednesday, July 12, 2017 / Notices asabaliauskas on DSKBBXCHB2PROD with NOTICES 11–12, 2017. A sample of agenda items to be discussed during the public session includes: An update on medicalrelated events; a discussion on medical event reporting and impact on safety culture; an update on the licensing guidance for yttrium-90 microsphere brachytherapy; a discussion on the training and experience requirements for authorized individuals for various modalities; an update on the patient release project; an update on Category 3 source security and accountability evaluation initiatives; a discussion on the nursing mother guidelines for exposure to diagnostic and therapeutic radiopharmaceuticals; and a discussion on the physical presence requirements for the Leksell Gamma Knife® IconTM. The agenda is subject to change. The current agenda and any updates will be available at http://www.nrc.gov/readingrm/doc-collections/acmui/meetings/ 2017.html or by emailing Ms. Sophie Holiday at the contact information below. Purpose: Discuss issues related to title 10 of the Code of Federal Regulations (10 CFR) part 35 Medical Use of Byproduct Material. Date and Time for Open Sessions: September 11, 2017, from 8:00 a.m. to 3:30 p.m. and September 12, 2017, from 8:00 a.m. to 4:00 p.m. Data and Time for Closed Sessions: September 11, 2017, from 7:00 a.m. to 8:00 a.m. and from 3:30 p.m. to 5:00 p.m. These sessions will be closed on September 11, 2017, for badging and enrollment for new members to the ACMUI and for annual required training, respectively. Address for Public Meeting: U.S. Nuclear Regulatory Commission, Two White Flint North Building, Room T2– B3, 11545 Rockville Pike, Rockville, Maryland 20852. Public Participation: Any member of the public who wishes to participate in the meeting in person or via phone should contact Ms. Holiday using the information below. The meeting will also be webcast live: video.nrc.gov. Contact Information: Ms. Sophie Holiday, email: sophie.holiday@nrc.gov, telephone: (301) 415–7865. Conduct of the Meeting Philip O. Alderson, M.D., will chair the meeting. Dr. Alderson will conduct the meeting in a manner that will facilitate the orderly conduct of business. The following procedures apply to public participation in the meeting: 1. Persons who wish to provide a written statement should submit an electronic copy to Ms. Holiday using the contact information listed above. All VerDate Sep<11>2014 17:54 Jul 11, 2017 Jkt 241001 submittals must be received by September 6, 2017, and must pertain to the topic on the agenda for the meeting. 2. Questions and comments from members of the public will be permitted during the meeting, at the discretion of the Chairman. 3. The draft transcript and meeting summary will be available on ACMUI’s Web site http://www.nrc.gov/readingrm/doc-collections/acmui/meetings/ 2017.html on or about October 24, 2017. 4. Persons who require special services, such as those for the hearing impaired, should notify Ms. Holiday of their planned attendance. This meeting will be held in accordance with the Atomic Energy Act of 1954, as amended (primarily Section 161a); the Federal Advisory Committee Act (5 U.S.C. App); and the Commission’s regulations in 10 CFR part 7. Dated at Rockville, Maryland this 6th day of July, 2017. For the U.S. Nuclear Regulatory Commission. Andrew L. Bates, Advisory Committee Management Officer. [FR Doc. 2017–14543 Filed 7–11–17; 8:45 am] BILLING CODE 7590–01–P PEACE CORPS Information Collection Request; Submission for OMB Review Peace Corps. 60-Day notice and request for comments. AGENCY: ACTION: The Peace Corps will be submitting the following information collection request to the Office of Management and Budget (OMB) for review and approval. The purpose of this notice is to allow 60 days for public comment in the Federal Register preceding submission to OMB. We are conducting this process in accordance with the Paperwork Reduction Act of 1995. DATES: Submit comments on or before September 11, 2017. ADDRESSES: Comments should be addressed to Denora Miller, FOIA/ Privacy Act Officer. Denora Miller can be contacted by telephone at 202–692– 1236 or email at pcfr@peacecorps.gov. Email comments must be made in text and not in attachments. FOR FURTHER INFORMATION CONTACT: Denora Miller at Peace Corps address above or at 202–692–1236. SUPPLEMENTARY INFORMATION: Title: Peace Corps Response Reference Forms. SUMMARY: PO 00000 Frm 00049 Fmt 4703 Sfmt 4703 OMB Control Number: 0420–0548. Type of Request: Revision of a currently approved collection. Affected Public: Individuals. Respondents Obligation to Reply: Voluntary. Burden to the Public: Estimated burden (hours) of the collection of information: a. Number of interviewed applicants: * 1,000. b. Number of references required per interviewed applicant: 2. c. Estimated number of reference forms received: 2,000. d. Frequency of response: One time. e. Completion time: 10 minutes. f. Annual burden hours: 333 hours. * Reference information is collected only if an applicant is contacted for an interview. General Description of Collection: Peace Corps Response uses the staff, personal and professional reference forms to learn from someone who knows the applicant and his or her background whether the applicant possesses the necessary characteristics and skills to serve as Peace Corps Response Volunteer. Request for Comment: Peace Corps invites comments on whether the proposed collections of information are necessary for proper performance of the functions of the Peace Corps, including whether the information will have practical use; the accuracy of the agency’s estimate of the burden of the proposed collection of information, including the validity of the information to be collected; and, ways to minimize the burden of the collection of information on those who are to respond, including through the use of automated collection techniques, when appropriate, and other forms of information technology. This notice is issued in Washington, DC, on July 6, 2017. Denora Miller, FOIA/Privacy Act Officer, Management. [FR Doc. 2017–14534 Filed 7–11–17; 8:45 am] BILLING CODE 6051–01–P PEACE CORPS Information Collection Request; Submission for OMB Review Peace Corps. 60-Day notice and request for comments. AGENCY: ACTION: The Peace Corps will be submitting the following information collection request to the Office of Management and Budget (OMB) for review and approval. The purpose of SUMMARY: E:\FR\FM\12JYN1.SGM 12JYN1

Agencies

[Federal Register Volume 82, Number 132 (Wednesday, July 12, 2017)]
[Notices]
[Pages 32207-32208]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-14543]


=======================================================================
-----------------------------------------------------------------------

NUCLEAR REGULATORY COMMISSION


Advisory Committee on the Medical Uses of Isotopes: Meeting 
Notice

AGENCY: U.S. Nuclear Regulatory Commission.

ACTION: Notice of meeting.

-----------------------------------------------------------------------

SUMMARY: The U.S. Nuclear Regulatory Commission will convene a meeting 
of the Advisory Committee on the Medical Uses of Isotopes (ACMUI) on 
September

[[Page 32208]]

11-12, 2017. A sample of agenda items to be discussed during the public 
session includes: An update on medical-related events; a discussion on 
medical event reporting and impact on safety culture; an update on the 
licensing guidance for yttrium-90 microsphere brachytherapy; a 
discussion on the training and experience requirements for authorized 
individuals for various modalities; an update on the patient release 
project; an update on Category 3 source security and accountability 
evaluation initiatives; a discussion on the nursing mother guidelines 
for exposure to diagnostic and therapeutic radiopharmaceuticals; and a 
discussion on the physical presence requirements for the Leksell Gamma 
Knife[supreg] IconTM. The agenda is subject to change. The 
current agenda and any updates will be available at http://www.nrc.gov/reading-rm/doc-collections/acmui/meetings/2017.html or by emailing Ms. 
Sophie Holiday at the contact information below.
    Purpose: Discuss issues related to title 10 of the Code of Federal 
Regulations (10 CFR) part 35 Medical Use of Byproduct Material.
    Date and Time for Open Sessions: September 11, 2017, from 8:00 a.m. 
to 3:30 p.m. and September 12, 2017, from 8:00 a.m. to 4:00 p.m.
    Data and Time for Closed Sessions: September 11, 2017, from 7:00 
a.m. to 8:00 a.m. and from 3:30 p.m. to 5:00 p.m. These sessions will 
be closed on September 11, 2017, for badging and enrollment for new 
members to the ACMUI and for annual required training, respectively.
    Address for Public Meeting: U.S. Nuclear Regulatory Commission, Two 
White Flint North Building, Room T2-B3, 11545 Rockville Pike, 
Rockville, Maryland 20852.
    Public Participation: Any member of the public who wishes to 
participate in the meeting in person or via phone should contact Ms. 
Holiday using the information below. The meeting will also be webcast 
live: video.nrc.gov.
    Contact Information: Ms. Sophie Holiday, email: 
sophie.holiday@nrc.gov, telephone: (301) 415-7865.

Conduct of the Meeting

    Philip O. Alderson, M.D., will chair the meeting. Dr. Alderson will 
conduct the meeting in a manner that will facilitate the orderly 
conduct of business. The following procedures apply to public 
participation in the meeting:
    1. Persons who wish to provide a written statement should submit an 
electronic copy to Ms. Holiday using the contact information listed 
above. All submittals must be received by September 6, 2017, and must 
pertain to the topic on the agenda for the meeting.
    2. Questions and comments from members of the public will be 
permitted during the meeting, at the discretion of the Chairman.
    3. The draft transcript and meeting summary will be available on 
ACMUI's Web site http://www.nrc.gov/reading-rm/doc-collections/acmui/meetings/2017.html on or about October 24, 2017.
    4. Persons who require special services, such as those for the 
hearing impaired, should notify Ms. Holiday of their planned 
attendance.
    This meeting will be held in accordance with the Atomic Energy Act 
of 1954, as amended (primarily Section 161a); the Federal Advisory 
Committee Act (5 U.S.C. App); and the Commission's regulations in 10 
CFR part 7.

    Dated at Rockville, Maryland this 6th day of July, 2017.

    For the U.S. Nuclear Regulatory Commission.
Andrew L. Bates,
Advisory Committee Management Officer.
[FR Doc. 2017-14543 Filed 7-11-17; 8:45 am]
BILLING CODE 7590-01-P